Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2025-12-31 @ 1:23 AM
Study NCT ID:
NCT05028634
Status:
COMPLETED
Last Update Posted:
2025-02-11
First Post:
2021-08-25
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-25
First Submit QC Date:
None
Study First Post Date:
2021-08-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-05
Results First Submit QC Date:
None
Results First Post Date:
2025-01-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-23
Last Update Post Date:
2025-02-11
Last Update Post Date Type:
ACTUAL